These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29702479)

  • 1. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
    Gu F; Ning J; Fan H; Wu C; Wang Y
    Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurisin A Complexed with 2,6-Di-
    Charoenwongpaiboon T; Oo A; Nasoontorn S; Rungrotmongkol T; Kanokmedhakul S; Mahalapbutr P
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
    Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
    Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and statistical optimization of alginate based stomach specific floating microcapsules of simvastatin.
    Premchandani TA; Barik BB
    Acta Pol Pharm; 2012; 69(4):751-61. PubMed ID: 22876619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
    Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
    Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility enhancement of simvastatin: a review.
    Murtaza G
    Acta Pol Pharm; 2012; 69(4):581-90. PubMed ID: 22876598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of solid dispersion of simvastatin.
    Silva TD; Arantes VT; Resende JA; Speziali NL; de Oliveira RB; Vianna-Soares CD
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1348-55. PubMed ID: 20545512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation.
    Pandya P; Gattani S; Jain P; Khirwal L; Surana S
    AAPS PharmSciTech; 2008; 9(4):1247-52. PubMed ID: 19115110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.
    Khan FM; Ahmad M; Idrees HA
    Drug Des Devel Ther; 2020; 14():4303-4313. PubMed ID: 33116417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
    Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
    Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics.
    Ahmed OA; Hosny KM; Al-Sawahli MM; Fahmy UA
    Drug Des Devel Ther; 2015; 9():655-62. PubMed ID: 25670883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
    Aloisio C; Longhi M
    Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.
    Jug M; Mennini N; Kövér KE; Mura P
    J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.
    Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z
    Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.